Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
- PMID: 35063123
- PMCID: PMC8765759
- DOI: 10.1016/S0140-6736(22)00090-3
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
Erratum in
-
Department of Error.Lancet. 2022 Feb 12;399(10325):628. doi: 10.1016/S0140-6736(22)00234-3. Lancet. 2022. PMID: 35151396 Free PMC article. No abstract available.
References
-
- WHO Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern. Statement 26 November, 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1....
-
- Dolgin E. Omicron is supercharging the COVID vaccine booster debate. Dec 2, 2021. https://www.nature.com/articles/d41586-021-03592-2 - PubMed
-
- European Medicines Agency EMA and ECDC recommendations on heterologous vaccination courses against COVID-19. Dec 7, 2021. https://www.ema.europa.eu/en/news/ema-ecdc-recommendations-heterologous-...
-
- European Medicines Agency Spikevax: EMA recommendation on booster. Oct 25, 2021. https://www.ema.europa.eu/en/news/spikevax-ema-recommendation-booster
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
